Michael Philip Barnes
- Botulinum toxin--mechanisms of action and clinical use in spasticityMichael Barnes
Hunters Moor Regional Neurorehabilitation Centre, University of Newcastle upon Tyne, Newcastle upon Tyne, UK
J Rehabil Med . 2003..Further studies also need to be done to confirm the place of botulinum toxin in the overall context of other treatment possibilities in the management of spasticity...
- Spasticity: a rehabilitation challenge in the elderlyM P Barnes
Hunters Moor Regional Neurorehabilitation Centre, University of Newcastle upon Tyne, UK
Gerontology 47:295-9. 2001..The advent of lycra garments for the overall management of more diffuse spasticity is now becoming both fashionable and effective...
- Spasticity in multiple sclerosisM P Barnes
Academic Unit of Neurological Rehabilitation, Hunters Moor Regional Neurological Rehabilitation Centre, Newcastle upon Tyne NE2 4NR, UK
Neurorehabil Neural Repair 17:66-70. 2003..Treatment of spasticity is suboptimal in a large proportion of the population, and the need for further information and education to health professionals and to people with MS is highlighted...
- Principles of neurological rehabilitationM P Barnes
Hunters Moor Regional Rehabilitation Centre, Newcastle upon Tyne, UK
J Neurol Neurosurg Psychiatry 74:iv3-iv7. 2003
- The use of botulinum toxin type-B in the treatment of patients who have become unresponsive to botulinum toxin type-A -- initial experiencesM P Barnes
Specialist Neurological Rehabilitation Services Division, Northgate and Prudhoe NHS Trust, Hunters Road, Newcastle upon Tyne, UK
Eur J Neurol 12:947-55. 2005..These findings demonstrate that botulinum toxin type-B has a place in the management of patients who have become non-responsive to type-A, but overall the responses to type-B toxin were disappointing...
- Sativex: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic painMichael Philip Barnes
Hunters Moor Regional Neurological Rehabilitation Centre, Newcastle upon Tyne, NE2 4NR, UK
Expert Opin Pharmacother 7:607-15. 2006..If ongoing studies replicate the results already observed, further approvals for the treatment of spasticity in multiple sclerosis and for neuropathic pain are likely...
- Efficacy and safety of NT 201 for upper limb spasticity of various etiologies--a randomized parallel-group studyM Barnes
14 Rake House Farm, North Shields, UK
Acta Neurol Scand 122:295-302. 2010..To assess efficacy and safety of two dilutions of botulinum neurotoxin type A NT 201 (Xeomin®) in patients with upper limb spasticity of diverse etiology...
- A pilot study of a comparison between a patient scored numeric rating scale and clinician scored measures of spasticity in multiple sclerosisKhalid Anwar
Walkergate Park International Centre for Neurorehabilitation, Newcastle upon Tyne, UK
NeuroRehabilitation 24:333-40. 2009..To assess the validity and reliability of a Numeric Rating Scale (NRS) for the measurement of spasticity in multiple sclerosis...
- Botulinum toxin for people with dystonia treated by an outreach nurse practitioner: a comparative study between a home and a clinic treatment serviceJ Whitaker
Academic Unit of Neurological Rehabilitation, Hunters Moor Regional Neurorehabilitation Centre, Newcastle upon Tyne, UK
Arch Phys Med Rehabil 82:480-4. 2001..The nurse practitioner provided a more flexible, much appreciated, safe, and cost-effective service for this client group. Wider use of outreach nurse practitioners for dystonia should be encouraged...
- A review of the properties and limitations of the Ashworth and modified Ashworth Scales as measures of spasticityA D Pandyan
Centre for Rehabilitation and Engineering Studies, University of Newcastle upon Tyne, UK
Clin Rehabil 13:373-83. 1999..Despite the current emphasis on treating spasticity, clinicians rarely measure it...
- Biomechanical examination of a commonly used measure of spasticityA D Pandyan
Centre for Rehabilitation and Engineering Studies, University of Newcastle, Stephenson Building, NE1 7RU, Newcastle upon Tyne, UK
Clin Biomech (Bristol, Avon) 16:859-65. 2001..Spasticity is an important neurological impairment for which many novel and expensive treatment options now exist. The antispastic effects of these techniques remain unexplored due to a paucity of valid outcome measures...
- Neurological rehabilitation in the communityM P Barnes
University of Newcastle upon Tyne, UK
J Rehabil Med 33:244-8. 2001..Although there is a reasonable body of evidence for both the acceptability and effectiveness of community rehabilitation there is a clear need for further research...
- Does spasticity result from hyperactive stretch reflexes? Preliminary findings from a stretch reflex characterization studyJ De J Salazar-Torres
Centre for Rehabilitation and Engineering Studies CREST, University of Newcastle upon Tyne, UK
Disabil Rehabil 26:756-60. 2004....